{"id":13194,"date":"2010-07-06T09:30:00","date_gmt":"2010-07-06T07:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/farmindustria-sugli-emendamenti-alla-manovra-critico-sergio-dompe\/"},"modified":"2010-07-06T09:30:00","modified_gmt":"2010-07-06T07:30:00","slug":"farmindustria-sugli-emendamenti-alla-manovra-critico-sergio-dompe","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/farmindustria-sugli-emendamenti-alla-manovra-critico-sergio-dompe\/","title":{"rendered":"Farmindustria: on the amendments to Maneuver critic Sergio Domp\u00e9"},"content":{"rendered":"

\"\"I criticize the President of Farmindustria Sergio Domp\u00e9 on the amendments to the Maneuver: if approved "they would be doubly unfair to the pharmaceutical industry" because the increase in the share of remuneration for pharmacies could end up unfairly at the expense of companies. The 3.65% reduction in wholesalers' margins could further reduce the industry margin, which is already the lowest among the main European countries. Furthermore, the "pharmaceutical industry is already called upon to contribute 600 million euros in savings on equivalent medicines, as well as with the costs deriving from the movement of another 600 million medicines from the hospital to the territory. A measure, the latter, which determines a conspicuous advantage for the pharmacies which will now find themselves distributing them".<\/p>\n

On the eve of the votes in the Budget Commission on the Maneuver, Confindustria takes the field in defense of the pharmaceutical industry: "It is unacceptable that further burdens are passed on to pharmaceutical companies, which have already suffered heavy cuts, even in this Maneuver". The concern is for the amendment of the rapporteur Antonio Azzollini (Pdl) which provides for the reduction of the margins of wholesalers to 1.22%, compared to the 3.65% of the Maneuver, leaving the pharmaceutical companies to pay the remaining part of the discount to the regions until 12\/31\/2010, on the basis of specific Aifa tables.<\/p>\n

Il Sole 24 Ore Pag.2 \u2013 04\/07\/2010 \"\"<\/p>","protected":false},"excerpt":{"rendered":"

Critico il Presidente di Farmindustria Sergio Dompé sugli emendamenti alla Manovra: se approvati "sarebbero doppiamente iniqui per l’industria farmaceutica" perché l’aumento della quota di remunerazione per le farmacie potrebbe finire ingiustamente a carico delle aziende. La riduzione del 3,65% dei margini dei grossisti potrebbe diminuire ulteriormente il margine dell’industria, che è già il più basso …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-13194","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/13194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=13194"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/13194\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=13194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=13194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=13194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}